219 related articles for article (PubMed ID: 18614535)
1. KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death.
Munirajan AK; Ando K; Mukai A; Takahashi M; Suenaga Y; Ohira M; Koda T; Hirota T; Ozaki T; Nakagawara A
J Biol Chem; 2008 Sep; 283(36):24426-34. PubMed ID: 18614535
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor KIF1Bβ regulates mitochondrial apoptosis in collaboration with YME1L1.
Ando K; Yokochi T; Mukai A; Wei G; Li Y; Kramer S; Ozaki T; Maehara Y; Nakagawara A
Mol Carcinog; 2019 Jul; 58(7):1134-1144. PubMed ID: 30859632
[TBL] [Abstract][Full Text] [Related]
3. Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN.
Teitz T; Wei T; Liu D; Valentine V; Valentine M; Grenet J; Lahti JM; Kidd VJ
Oncogene; 2002 Mar; 21(12):1848-58. PubMed ID: 11896617
[TBL] [Abstract][Full Text] [Related]
4. RNA helicase A is a downstream mediator of KIF1Bβ tumor-suppressor function in neuroblastoma.
Chen ZX; Wallis K; Fell SM; Sobrado VR; Hemmer MC; Ramsköld D; Hellman U; Sandberg R; Kenchappa RS; Martinson T; Johnsen JI; Kogner P; Schlisio S
Cancer Discov; 2014 Apr; 4(4):434-51. PubMed ID: 24469107
[TBL] [Abstract][Full Text] [Related]
5. No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
Hogarty MD; Winter CL; Liu X; Guo C; White PS; Look AT; Brodeur GM; Maris JM
Cancer Res; 2002 Nov; 62(22):6481-4. PubMed ID: 12438240
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.
Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Shishikura T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Tomioka N; Sakiyama S; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Nakagawara A
Oncogene; 2000 Aug; 19(37):4302-7. PubMed ID: 10980605
[TBL] [Abstract][Full Text] [Related]
7. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
Oncogene; 1999 Jan; 18(4):1061-6. PubMed ID: 10023682
[TBL] [Abstract][Full Text] [Related]
8. Genomic structure and mutational analysis of the human KIF1Balpha gene located at 1p36.2 in neuroblastoma.
Chen YY; Takita J; Chen YZ; Yang HW; Hanada R; Yamamoto K; Hayashi Y
Int J Oncol; 2003 Sep; 23(3):737-44. PubMed ID: 12888911
[TBL] [Abstract][Full Text] [Related]
9. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.
Schlisio S; Kenchappa RS; Vredeveld LC; George RE; Stewart R; Greulich H; Shahriari K; Nguyen NV; Pigny P; Dahia PL; Pomeroy SL; Maris JM; Look AT; Meyerson M; Peeper DS; Carter BD; Kaelin WG
Genes Dev; 2008 Apr; 22(7):884-93. PubMed ID: 18334619
[TBL] [Abstract][Full Text] [Related]
10. Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA.
Fell SM; Li S; Wallis K; Kock A; Surova O; Rraklli V; Höfig CS; Li W; Mittag J; Henriksson MA; Kenchappa RS; Holmberg J; Kogner P; Schlisio S
Genes Dev; 2017 May; 31(10):1036-1053. PubMed ID: 28637693
[TBL] [Abstract][Full Text] [Related]
11. KIF1Bβ increases ROS to mediate apoptosis and reinforces its protein expression through O
Angelina C; Tan ISY; Choo Z; Lee OZJ; Pervaiz S; Chen ZX
Sci Rep; 2017 Dec; 7(1):16867. PubMed ID: 29203804
[TBL] [Abstract][Full Text] [Related]
12. Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization.
Scaruffi P; Parodi S; Mazzocco K; Defferrari R; Fontana V; Bonassi S; Tonini GP
Mol Diagn; 2004; 8(2):93-100. PubMed ID: 15527323
[TBL] [Abstract][Full Text] [Related]
13. Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism.
Mandriota SJ; Valentijn LJ; Lesne L; Betts DR; Marino D; Boudal-Khoshbeen M; London WB; Rougemont AL; Attiyeh EF; Maris JM; Hogarty MD; Koster J; Molenaar JJ; Versteeg R; Ansari M; Gumy-Pause F
Oncotarget; 2015 Jul; 6(21):18558-76. PubMed ID: 26053094
[TBL] [Abstract][Full Text] [Related]
14. Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo.
Chen Z; Lin Y; Barbieri E; Burlingame S; Hicks J; Ludwig A; Shohet JM
Neoplasia; 2009 Aug; 11(8):753-62. PubMed ID: 19649205
[TBL] [Abstract][Full Text] [Related]
15. p53 is a direct transcriptional target of MYCN in neuroblastoma.
Chen L; Iraci N; Gherardi S; Gamble LD; Wood KM; Perini G; Lunec J; Tweddle DA
Cancer Res; 2010 Feb; 70(4):1377-88. PubMed ID: 20145147
[TBL] [Abstract][Full Text] [Related]
16. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
[TBL] [Abstract][Full Text] [Related]
17. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.
Altungoz O; Aygun N; Tumer S; Ozer E; Olgun N; Sakizli M
Cancer Genet Cytogenet; 2007 Jan; 172(2):113-9. PubMed ID: 17213019
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastoma.
He J; Gu L; Zhang H; Zhou M
Cell Cycle; 2011 Sep; 10(17):2994-3002. PubMed ID: 21862876
[TBL] [Abstract][Full Text] [Related]
19. XAF1 promotes neuroblastoma tumor suppression and is required for KIF1Bβ-mediated apoptosis.
Choo Z; Koh RY; Wallis K; Koh TJ; Kuick CH; Sobrado V; Kenchappa RS; Loh AH; Soh SY; Schlisio S; Chang KT; Chen ZX
Oncotarget; 2016 Jun; 7(23):34229-39. PubMed ID: 27097110
[TBL] [Abstract][Full Text] [Related]
20. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.
Petroni M; Veschi V; Prodosmo A; Rinaldo C; Massimi I; Carbonari M; Dominici C; McDowell HP; Rinaldi C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Soddu S; Giannini G
Mol Cancer Res; 2011 Jan; 9(1):67-77. PubMed ID: 21173028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
